Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CETP | P11597 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | UBE2N | P61088 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313926 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL932976 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| Hexane SCHEMBL17093132 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10563903 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL7063457 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL15013420 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL25243382 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL325349 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL118392 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10571108 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4731736-A1 | COMPOSITION COMPRISING BIOSURFACTANT AND MANGANESE | Evonik Operations GmbH (DE) | 2026-04-29 | — | — | EP | claimed |
| US-20260102329-A1 | BIOBASED POLYGLYCERYL ESTERS AND COMPOSITIONS COMPRISING THE SAME | INOLEX INVESTMENT CORPORATION (US) | 2026-04-16 | — | — | US | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| WO-2026041513-A1 | POLYGLYCEROL PARTIAL ESTERS OF SHORT-CHAIN CARBOXYLIC ACIDS | EVONIK OPERATIONS GMBH (DE) | 2026-02-26 | — | — | WO | claimed |
| EP-4385488-B1 | CONDITIONING COMPOSITION FOR KERATIN FIBERS, ESPECIALLY HUMAN HAIR | KAO CORP (JP) | 2025-12-17 | — | — | EP | claimed |
| WO-2025224176-A1 | CONDITIONING COMPOSITION FOR KERATIN FIBERS | KAO GERMANY GMBH (DE) | 2025-10-30 | — | — | WO | claimed |
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | INOLEX INVESTMENT CORPORATION (US) | 2025-09-16 | — | — | US | claimed |
| WO-2025132038-A2 | COSMETIC COMPOSITION COMPRISING A SYNERGISTIC ANTIMICROBIAL COMPLEX | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) | 2025-06-26 | — | — | WO | claimed |
| EP-4554551-A1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | Symrise AG (DE) | 2025-05-21 | — | — | EP | claimed |
| CN-105025712-B | Antimicrobial compositions | 西姆莱斯股份公司 | 2020-05-05 | — | — | CN | claimed |
| US-20160100574-A1 | Antimicrobial Compositions Comprising Glyceryl Ethers | SYMRISE AG (DE) | 2016-04-14 | — | — | US | claimed |
| US-20160015031-A1 | Antimicrobial Compositions | SYMRISE AG (DE) | 2016-01-21 | — | — | US | claimed |
| WO-2014191258-A2 | ANTIMICROBIAL COMPOSITIONS COMPRISING GLYCERYL ETHERS | SYMRISE AG (DE) | 2014-12-04 | — | — | WO | claimed |
| WO-2014135650-A1 | ANTIMICROBIAL COMPOSITIONS | SYMRISE AG (DE) | 2014-09-12 | — | — | WO | claimed |
| EP-0747047-B1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | ROCHE POSAY LAB PHARMA (FR) | 1998-07-15 | — | — | EP | claimed |
| EP-0747047-A1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | LA ROCHE POSAY Laboratoire Pharmaceutique (FR) | 1996-12-11 | — | — | EP | claimed |
| EP-0547727-B1 | Skin and hands composition containing disinfectants and antiseptics | SCHUELKE & MAYR GMBH (DE) | 1996-03-13 | — | — | EP | claimed |
| EP-0662529-A1 | Degreasing cleaner and method for cleaning oil-deposited material | Mitsubishi Chemical Corporation (JP) | 1995-07-12 | — | — | EP | claimed |
| EP-0547727-A2 | Skin and hands composition containing disinfectants and antiseptics | SCHÀLKE & MAYR GMBH (DE) | 1993-06-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | SGMS1, MGLL, CCL11 | LMNA 3468/4885CYP2D6 936/4885SPHK1 923/4885 |
| US-20260102329-A1 | BIOBASED POLYGLYCERYL ESTERS AND COMPOSITIONS COMPRISING THE SAME | MGLL, LIPA, ELOVL1 | LMNA 652/4885CYP2D6 729/4885SPHK1 663/4885 |
| US-20160100574-A1 | Antimicrobial Compositions Comprising Glyceryl Ethers | MGLL, PGLS, GPX4 | LMNA 2085/4885CYP2D6 602/4885SPHK1 855/4885 |
| US-20160015031-A1 | Antimicrobial Compositions | CUTA, ARG1, POLR1C | LMNA 4277/4885CYP2D6 1065/4885SPHK1 2894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.